touchNEUROLOGY met with Robert Shapiro (Larner College of Medicine at the University of Vermont, Burlington, VT, USA) to discuss the impact of COVID-19 on individuals with migraine.
The abstract ‘Migraine Is Associated With Higher Incidence of COVID-19, and Higher Frequency of COVID-19 Symptoms, but Lower COVID-19-Associated Health Care Resource Utilization Rates’ was presented at the American Headache Society (AHS) Virtual Annual Scientific Meeting 2021, 3-6 June 2021.
Questions:
- What is known about the risk of COVID-19 incidence and mortality among individuals with migraine? (0:16)
- Could you give us a brief overview of your National Health and Wellness Survey study and its findings? (2:44)
- What hypotheses have been proposed to explain these findings? (4:49)
Disclosures: Robert Shapiro has provided research consultation for Eli Lilly and Lundbeck within the past 12 months.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Katey Gabrysch.
Filmed as a highlight of AHS Virtual Annual Scientific Meeting 2021.
